Skip to main content

Table 6 Relationship between p53 overexpression and clinicopathologic parameters

From: Prognostic role of serum p53 antibodies in lung cancer

Ā 

No. of cases

No. of patients with p53 overexpression

Age (years)

Ā Ā 

ā‰¤60

27

16 (59.3%)

>60

104

59 (56.7%)

Total

131

75 (57.3%)

Sex

Ā Ā 

Male

101

57 (56.4%)

Female

30

18 (60.0%)

Total

131

75 (57.3%)

Histological type

Ā Ā 

NSCLC

Ā Ā 

Adenocarcinoma

59

26 (44.1%)

Squamous cell carcinoma

46

33 (71.7%)

Bronchioloalveolar carcinoma

5

1 (20.0%)

Large cell carcinoma

4

4 (100%)

Anaplastic carcinoma

4

4 (100%)

Mixed carcinoma

5

1 (20.0%)

SCLC

8

6 (75.0%)

Total

131

75 (57.3%)

NSCLC stage

Ā Ā 

I

62

35 (56.4%)

II

17

9 (52.9%)

III

22

15 (68.2%)

IV

18

8 (44.4%)

Missing

4

2 (50.0%)

Total

123

69 (56.1%)

NSCLC grade

Ā Ā 

G1

3

1 (33.3%)

G2

53

21 (39.6%)

G3

60

40 (66.7%)

Missing

7

7 (100%)

Total

123

69 (56.1%)